Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of three medications: efavirenz (an antiretroviral medication used for HIV treatment), methadone (an opioid used for pain management and opioid dependence), and tizanidine (a muscle relaxant). When used together, significant drug interactions may occur. Efavirenz substantially reduces methadone plasma concentrations through induction of CYP3A4 and possibly CYP2B6 enzymes, which can precipitate opioid withdrawal symptoms in patients on methadone maintenance therapy. Tizanidine is a short-acting muscle relaxant that works as an alpha-2 adrenergic receptor agonist and may cause additional sedation when combined with methadone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on efavirenz + methadone + tizanidine.